ATI RN
Effects of Pharmacological Treatments on Clients Across a Lifespan Questions
Question 1 of 5
A 49-year-old man with hypertension comes to the physician for a follow-up examination. At his last visit 2 months ago, his serum total cholesterol concentration was 320 mg/dL. He then began a low-cholesterol diet. His blood pressure is 145/95 mm Hg. Physical examination shows no other abnormalities. Serum studies show a total cholesterol concentration of 310 mg/dL. Kidney and liver function test results are within normal limits. The most appropriate pharmacotherapy for this patient is a drug that has which of the following mechanisms of action?
Correct Answer: B
Rationale: Persistent hypercholesterolemia (310 mg/dL) despite diet indicates a need for a statin, which inhibits HMG-CoA reductase (E), reducing hepatic cholesterol synthesis and upregulating LDL receptors to lower serum cholesterol. PPAR activation is for fibrates (triglycerides), VLDL reduction for niacin, bile acid sequestration for resins, and cholesterol absorption inhibition for ezetimibe—statins are most effective for LDL here.
Question 2 of 5
Pick out the appropriate alimentary route of administration when passage of drugs through liver is minimized:
Correct Answer: C
Rationale: The appropriate alimentary route of administration when passage of drugs through the liver is to be minimized is option C) Rectal. When a drug is administered rectally, it bypasses the liver and enters the bloodstream directly through the rectal mucosa, thus avoiding the first-pass metabolism in the liver. This can be beneficial for drugs that are extensively metabolized in the liver or those that may cause liver toxicity. Option A) Oral administration is incorrect in this scenario because drugs taken orally pass through the liver before entering the systemic circulation, which can result in significant metabolism by the liver. Option B) Transdermal administration involves drug absorption through the skin and is not directly related to liver metabolism. Option D) Intraduodenal administration involves delivering drugs directly into the duodenum, which does not bypass the liver and can still result in first-pass metabolism. In an educational context, understanding the different routes of drug administration is crucial for healthcare professionals to make informed decisions about the most appropriate route based on the pharmacological effects desired and the specific needs of the patient. Knowledge of how drug metabolism occurs in the liver and the impact of first-pass metabolism can help in optimizing drug therapy for clients across the lifespan.
Question 3 of 5
For the calculation of the volume of distribution (Vd) one must take into account:
Correct Answer: A
Rationale: The correct answer is A) Concentration of a substance in plasma when calculating the volume of distribution (Vd). When calculating Vd, the concentration of a substance in the plasma is crucial because Vd is a pharmacokinetic parameter that helps determine how a drug is distributed throughout the body. It indicates the theoretical volume that would be necessary to contain the total amount of drug in the body at the same concentration observed in the plasma. Therefore, the concentration in plasma directly relates to the Vd calculation. Option B) Concentration of substance in urine is incorrect because Vd is not determined based on the concentration of the substance in urine, but rather in plasma, as it reflects the distribution of the drug within the body. Option C) Therapeutic width of drug action is incorrect as it refers to the range of drug concentrations in the body that produce the desired therapeutic effect. It is not directly related to the calculation of Vd. Option D) A daily dose of drug is incorrect as it is related to dosing calculations and not to the calculation of Vd, which is specifically based on the concentration of the substance in plasma. Understanding how to calculate pharmacokinetic parameters like Vd is essential for healthcare professionals to optimize drug therapy and ensure safe and effective treatment for clients across the lifespan. By grasping these concepts, healthcare providers can make informed decisions about drug dosing, monitoring, and adjustments to achieve desired therapeutic outcomes while minimizing adverse effects.
Question 4 of 5
In case of liver disorders accompanied by a decline in microsomal enzyme activity the duration of action of some drugs is:
Correct Answer: B
Rationale: In the case of liver disorders accompanied by a decline in microsomal enzyme activity, the duration of action of some drugs is **enlarged**. This is because microsomal enzymes, primarily found in the liver, play a crucial role in metabolizing many drugs. When their activity is reduced due to liver dysfunction, the breakdown of drugs slows down, leading to a longer duration of action. Option A) **Decreased** is incorrect because a decline in microsomal enzyme activity would not speed up the breakdown of drugs, resulting in a decreased duration of action. Option C) **Remained unchanged** is incorrect because if the liver's ability to metabolize drugs is compromised, it would impact the duration of action of drugs, making this option inaccurate. Option D) **Changed insignificantly** is incorrect because a decline in microsomal enzyme activity can significantly alter the pharmacokinetics of drugs, affecting their duration of action. Understanding the impact of liver disorders on drug metabolism is vital for healthcare professionals to ensure appropriate dosing and monitoring of pharmacological treatments in clients across the lifespan. This knowledge is crucial in preventing adverse effects and optimizing therapeutic outcomes, especially in vulnerable populations such as the elderly or pediatric patients.
Question 5 of 5
An agonist is a substance that:
Correct Answer: B
Rationale: The correct answer is B) Interacts with the receptor and initiates changes in cell function, producing various effects. An agonist is a substance that binds to a receptor and activates it, leading to a biological response. This is the fundamental mechanism of action for many drugs used in pharmacological treatments. By binding to the receptor and triggering a cellular response, agonists can mimic the actions of endogenous substances in the body or enhance their effects. Option A is incorrect because an agonist does produce an effect by interacting with the receptor. Option C is incorrect as it describes the mechanism of action of a different type of drug called a potentiator, which enhances the effect of another substance. Option D is incorrect as it does not accurately describe the role of an agonist in pharmacology. Understanding the concept of agonists is crucial in pharmacology as it underpins the rationale for using specific drugs to elicit desired therapeutic effects in patients across the lifespan. Knowing how agonists work helps healthcare professionals make informed decisions when selecting pharmacological treatments for their clients.